AAAAAA
Results:
1-9
|
Results: 9
Authors:
Avigdor, A
Raanani, P
Levi, I
Hardan, I
Ben-Bassat, I
Citation: A. Avigdor et al., Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma, LEUK LYMPH, 42(4), 2001, pp. 683
Authors:
Bank, I
Amariglio, N
Reshef, A
Hardan, I
Confino, Y
Trau, H
Shtrasburg, S
Langevitz, P
Monselise, Y
Shalit, M
Rechavi, G
Citation: I. Bank et al., The hypereosinophilic syndrome associated with CD4(+)CD3(-) helper type 2 (Th2) lymphocytes, LEUK LYMPH, 42(1-2), 2001, pp. 123-133
Authors:
Cohen, N
Rozenfeld-Granot, G
Hardan, I
Brok-Simoni, F
Amariglio, N
Rechavi, G
Trakhtenbrot, L
Citation: N. Cohen et al., Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis, CANC GENET, 128(2), 2001, pp. 114-119
Authors:
Stemmer, SM
Pfeffer, MR
Rizel, S
Hardan, I
Goffman, J
Gezin, A
Neumann, A
Kitsios, P
Alezra, D
Brenner, HJ
Citation: Sm. Stemmer et al., Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma, CANCER, 91(11), 2001, pp. 1983-1991
Authors:
Bank, I
Hardan, I
Lokshin, E
Nas, D
Miron, S
Ohad, D
Spong, S
Garrod, DR
Citation: I. Bank et al., Parenteral administration of an activating monoclonal antibody to the alpha 1 beta 1 integrin in dogs, IMMUNOBIOL, 202(3), 2000, pp. 239-253
Authors:
Cohen, N
Novikov, I
Hardan, I
Esa, A
Brok-Simoni, F
Amariglio, N
Rechavi, G
Ben-Bassat, I
Trakhtenbrot, L
Citation: N. Cohen et al., Standardization criteria for the detection of BCR/ABL fusion in interphasenuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization, CANC GENET, 123(2), 2000, pp. 102-108
Authors:
Kneller, A
Raanani, P
Hardan, I
Avigdor, A
Levi, I
Berkowicz, M
Ben-Bassat, I
Citation: A. Kneller et al., Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug, BR J HAEM, 108(2), 2000, pp. 391-393
Authors:
Raanani, P
Shpilberg, O
Gillis, S
Avigdor, A
Hardan, I
Berkowicz, M
Sofer, O
Lossos, I
Chetrit, A
Ben-Yehuda, D
Bell-Bassat, I
Citation: P. Raanani et al., Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine, LEUK RES, 23(8), 1999, pp. 695-700
Authors:
Apter, S
Zaks, N
Hardan, I
Amital, M
Langevitz, P
Livneh, A
Citation: S. Apter et al., Calcification in untreated non-Hodgkin's mediastinal lymphoma, SOUTH MED J, 91(2), 1998, pp. 212-213
Risultati:
1-9
|